✨ Medicine Distribution Consents




NEW ZEALAND GAZETTE, No. 34 β€” 2 APRIL 2015

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Actemra
Active Ingredient: Tocilizumab 162mg
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany

Product: Apo-Sumatriptan (Prescription)
Active Ingredient: Sumatriptan succinate 70.08mg equivalent to Sumatriptan 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India

Product: Apo-Sumatriptan (Restricted)
Active Ingredient: Sumatriptan succinate 70.08mg equivalent to Sumatriptan 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India

Product: Apo-Sumatriptan
Active Ingredient: Sumatriptan succinate 140.15mg equivalent to Sumatriptan 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India

Product: Ipca-Sumatriptan
Active Ingredient: Sumatriptan succinate 70.08mg equivalent to Sumatriptan 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India

Product: Ipca-Sumatriptan
Active Ingredient: Sumatriptan succinate 140.15mg equivalent to Sumatriptan 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India

Product: Valganciclovir Mylan
Active Ingredient: Valganciclovir hydrochloride 496.3mg equivalent to Valganciclovir 450mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Laboratories Limited, Maharashtra State India

Dated this 27th day of March 2015.

SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2015-go1855

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and set out in the Schedule hereto:

Schedule

41



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2015, No 34





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
27 March 2015
Medicines, Distribution, Consent, Medicines Act 1981, New Zealand Sponsor
  • SARAH READER, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Medicines Act 1981, New Zealand Sponsor